L. Jayaraman

1.8k total citations · 1 hit paper
7 papers, 1.5k citations indexed

About

L. Jayaraman is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, L. Jayaraman has authored 7 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 5 papers in Oncology and 1 paper in Pulmonary and Respiratory Medicine. Recurrent topics in L. Jayaraman's work include Cancer-related Molecular Pathways (5 papers), RNA modifications and cancer (4 papers) and Advanced Breast Cancer Therapies (1 paper). L. Jayaraman is often cited by papers focused on Cancer-related Molecular Pathways (5 papers), RNA modifications and cancer (4 papers) and Advanced Breast Cancer Therapies (1 paper). L. Jayaraman collaborates with scholars based in United States and Iceland. L. Jayaraman's co-authors include Carol Prives, Xiaohong Chen, Kanneganti Murthy, Tom Curran, Chunhong Zhu, Steven Xanthoudakis, James L. Manley, Michael Bustin, Ganesh Venkataraman and Ganlin Zhao and has published in prestigious journals such as Genes & Development, Annals of Oncology and Cellular and Molecular Life Sciences.

In The Last Decade

L. Jayaraman

7 papers receiving 1.5k citations

Hit Papers

p53 levels, functional domains, and DNA damage determine ... 1996 2026 2006 2016 1996 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
L. Jayaraman United States 7 1.1k 833 231 184 126 7 1.5k
Xiangao Sun United States 12 1.3k 1.1× 497 0.6× 167 0.7× 224 1.2× 129 1.0× 13 1.6k
Jerry Williams United States 5 945 0.8× 840 1.0× 177 0.8× 268 1.5× 48 0.4× 8 1.5k
Kevin G. McLure United States 16 1.6k 1.4× 794 1.0× 110 0.5× 236 1.3× 104 0.8× 24 1.9k
Tiziana Bruno Italy 22 1.4k 1.2× 674 0.8× 86 0.4× 337 1.8× 162 1.3× 52 1.7k
Kevin P. Rice United States 8 707 0.6× 605 0.7× 149 0.6× 170 0.9× 40 0.3× 10 1.1k
Gennadi V. Glinsky United States 18 1.3k 1.1× 593 0.7× 158 0.7× 261 1.4× 571 4.5× 22 1.9k
Steven J. Berberich United States 20 1.1k 0.9× 722 0.9× 177 0.8× 260 1.4× 46 0.4× 32 1.3k
N D Marchenko United States 15 1.4k 1.2× 1.0k 1.2× 247 1.1× 339 1.8× 147 1.2× 16 1.8k
M. Gloria Luciani United Kingdom 15 812 0.7× 519 0.6× 69 0.3× 163 0.9× 80 0.6× 18 1.2k
L. Chessa Italy 13 1.8k 1.5× 1.1k 1.3× 138 0.6× 535 2.9× 67 0.5× 18 2.0k

Countries citing papers authored by L. Jayaraman

Since Specialization
Citations

This map shows the geographic impact of L. Jayaraman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L. Jayaraman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L. Jayaraman more than expected).

Fields of papers citing papers by L. Jayaraman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L. Jayaraman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L. Jayaraman. The network helps show where L. Jayaraman may publish in the future.

Co-authorship network of co-authors of L. Jayaraman

This figure shows the co-authorship network connecting the top 25 collaborators of L. Jayaraman. A scholar is included among the top collaborators of L. Jayaraman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L. Jayaraman. L. Jayaraman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
O’Keefe, Stephen J., Jean Hoffman‐Censits, Roger B. Cohen, et al.. (2016). Efficacy of the nanoparticle–drug conjugate CRLX101 in combination with bevacizumab in metastatic renal cell carcinoma: results of an investigator-initiated phase I–IIa clinical trial. Annals of Oncology. 27(8). 1579–1585. 47 indexed citations
2.
Roy, Sucharita, Jay Duffner, He Zhou, et al.. (2011). Bioactivity screening of partially desulfated low-molecular-weight heparins: A structure/activity relationship study. Glycobiology. 21(9). 1194–1205. 31 indexed citations
3.
Jayaraman, L. & Carol Prives. (1999). Covalent and noncovalent modifiers of the p53 protein. Cellular and Molecular Life Sciences. 55(1). 76–87. 121 indexed citations
4.
Jayaraman, L., et al.. (1998). High mobility group protein-1 (HMG-1) is a unique activator of p53. Genes & Development. 12(4). 462–472. 273 indexed citations
5.
Jayaraman, L., Kanneganti Murthy, Chunhong Zhu, et al.. (1997). Identification of redox/repair protein Ref-1 as a potent activator of p53.. Genes & Development. 11(5). 558–570. 403 indexed citations
6.
Chen, Xiaohong, et al.. (1996). p53 levels, functional domains, and DNA damage determine the extent of the apoptotic response of tumor cells.. Genes & Development. 10(19). 2438–2451. 610 indexed citations breakdown →
7.
Prives, Carol, Jill Bargonetti, George E. Farmer, et al.. (1994). DNA-binding Properties of the p53 Tumor Suppressor Protein. Cold Spring Harbor Symposia on Quantitative Biology. 59(0). 207–213. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026